Compare IPSC & BUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | BUUU |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | United States | Hong Kong |
| Employees | 78 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.6M | 305.2M |
| IPO Year | 2021 | 2024 |
| Metric | IPSC | BUUU |
|---|---|---|
| Price | $1.92 | $38.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | ★ 386.4K | 63.1K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $347.19 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $5.70 |
| 52 Week High | $2.97 | $45.25 |
| Indicator | IPSC | BUUU |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 68.92 |
| Support Level | $1.92 | $14.04 |
| Resistance Level | $2.39 | $38.90 |
| Average True Range (ATR) | 0.10 | 4.23 |
| MACD | -0.01 | 0.68 |
| Stochastic Oscillator | 7.35 | 58.63 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.